tiprankstipranks
Company Announcements

McPherson’s Limited Reports 1H25 Financial Results Amid Strategic Transformation

Story Highlights
  • McPherson’s Limited operates in health, wellness, and beauty, focusing on core brands.
  • The company reported a revenue decline but is progressing with strategic transformation.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
McPherson’s Limited Reports 1H25 Financial Results Amid Strategic Transformation

Mcpherson’S Limited ( (AU:MCP) ) has shared an announcement.

McPherson’s Limited announced a challenging first half of the 2025 financial year, with revenue from continuing operations declining by 7.6% to $70.7 million. The company reported a statutory net loss after tax of $0.9 million, compared to a net profit of $1.6 million in the previous period. Despite these setbacks, McPherson’s is making progress on its transformation strategy, supported by a strong balance sheet. The company is implementing a new operating model that will transition to third-party warehousing and logistics, aiming to streamline operations and focus on core brands. This strategic shift is expected to address residual fixed costs and create a scalable cost base for future growth.

More about Mcpherson’S Limited

McPherson’s Limited operates in the health, wellness, and beauty industry, focusing on core brands such as Manicare, Lady Jayne, Dr LeWinn’s, Swisspers, and Fusion Health. The company has recently divested its Multix brand and is transitioning to a new operating model to enhance efficiency and focus on its primary market segments.

YTD Price Performance: 1.13%

Average Trading Volume: 1,700

Technical Sentiment Consensus Rating: Buy

Current Market Cap: €27.49M

See more insights into MCP stock on TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1